Tata Elxsi Limited
Tata Elxsi Limited's board has recommended a dividend of ₹75 per equity share for the financial year ended March 31, 2026. This recommendation will be presented for shareholder approval at the 37th Annual General Meeting on June 24, 2026.
Jun 02 2026 17:22:54
Tata Elxsi Limited
Tata Elxsi Limited will convene its 37th Annual General Meeting on June 24, 2026, via video conferencing. The company has also fixed June 10, 2026, as the record date for dividend entitlement, with payments to be made on or after June 30, 2026.
Jun 01 2026 18:34:46
Tata Elxsi Ltd - 500408 - Announcement Under Regulation 30 - Letter Sent To Shareholders Of The Company
Tata Elxsi has scheduled its 37th Annual General Meeting for June 24, 2026, to be held via video conferencing. The record date for dividend is set for June 10, 2026, with dividend payments expected on or after June 30, 2026.
Jun 01 2026 18:33:15
Tata Elxsi Limited
Tata Elxsi's Board of Directors has recommended a final dividend of Rs. 75 per equity share for the financial year ended March 31, 2026. The record date for determining eligible shareholders is June 10, 2026, with payment to be made on or after June 30, 2026, subject to approval at the upcoming AGM.
Jun 01 2026 16:05:36
Tata Elxsi launches AI tool to help healthcare firms get medical software approved faster
Tata Elxsi has launched AnaTel™, an AI-native software development platform developed in collaboration with OpenAna, aimed at accelerating software development and generating regulatory-grade documentation for healthcare and medical technology companies. The platform is designed to reduce development cycle times by up to 60% and addresses increasing regulatory demands for AI-enabled device software, making its debut at DeviceTalks Boston 2026.
May 27 2026 17:16:05
Tata Elxsi Limited
Tata Elxsi announced the launch of AnaTel™, an AI-native software development platform for healthcare and med-tech. The platform, co-developed with OpenAna, aims to accelerate software development and enhance regulatory compliance.
May 27 2026 16:14:36
Tata Elxsi Limited
Tata Elxsi launched AnaTel™, an AI-native software development platform for healthcare and med-tech. This platform, co-developed with OpenAna, is designed to accelerate regulatory-ready software engineering and reduce development cycle times by up to 60%.
May 27 2026 16:14:36
Tata Elxsi Ltd - 500408 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Tata Elxsi launched AnaTel™, an AI-native software development platform for healthcare and med-tech, co-developed with OpenAna. This platform aims to accelerate software development and reduce development cycle times by up to 60% for medical device companies.
May 27 2026 16:12:42
Tata Elxsi Ltd - 500408 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Tata Elxsi launched ViTel™, a new AI-powered Material Intelligence solution for Med-Tech. This solution, co-developed with Viridium AI, helps medical device manufacturers with sourcing, engineering, quality, and regulatory compliance.
May 26 2026 16:19:07
Tata Elxsi Limited
Tata Elxsi informed shareholders about tax deduction at source (TDS) rules for the recommended final dividend of Rs. 75 per equity share for FY26. Shareholders can submit relevant forms by June 10, 2026, to avail lower or no TDS, as per Income Tax Act, 2025 provisions.
May 19 2026 19:35:26
Read More